We are live on ! Find out more
TRAW icon

Traws Pharma
TRAW

24 hedge funds and large institutions have $1.04M invested in Traws Pharma in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% more capital invested

Capital invested by funds: $1.01M → $1.04M (+$32.4K)

0.03% less ownership

Funds ownership: 0.3% → 0.27% (-0.03%)

14% less funds holding

Funds holding: 28 → 24 (-4)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

86% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 7

Holders
24
Holders Change
-4
Holders Change %
-14.29%
% of All Funds
0.38%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
1
Reduced
7
Closed
6
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$147K

Top Buyers

Rank Fund Capital Flow
1
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$24.6K
2
TRCT
Tower Research Capital (TRC)
New York
+$4.54K
3
Osaic Holdings
Osaic Holdings
Arizona
+$865
4
UBS Group
UBS Group
Switzerland
+$108

Top Sellers

Rank Fund Capital Flow
1
BPA
Beacon Pointe Advisors
California
-$22.7K
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$20.3K
3
Millennium Management
Millennium Management
New York
-$20K
4
Renaissance Technologies
Renaissance Technologies
New York
-$19.8K
5
Citadel Advisors
Citadel Advisors
Florida
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$455K – – –
BlackRock
2
BlackRock
New York
$182K – – –
Geode Capital Management
3
Geode Capital Management
Massachusetts
$124K – – –
Renaissance Technologies
4
Renaissance Technologies
New York
$106K -$19.8K -914 -14%
State Street
5
State Street
Massachusetts
$38.6K – – –
Northern Trust
6
Northern Trust
Illinois
$22.5K – – –
Susquehanna International Group
7
Susquehanna International Group
Pennsylvania
$20.7K +$24.6K +1,136 New
Two Sigma Advisers
8
Two Sigma Advisers
New York
$19.5K -$20.3K -936 -47%
TSS
9
Two Sigma Securities
New York
$14.8K -$9.91K -458 -36%
HWA
10
Hillcrest Wealth Advisors
New Jersey
$12.2K – – –
UBS Group
11
UBS Group
Switzerland
$10.7K +$108 +5 +0.9%
BPA
12
Beacon Pointe Advisors
California
$9.59K -$22.7K -1,049 -67%
Morgan Stanley
13
Morgan Stanley
New York
$7.94K – – –
Jane Street
14
Jane Street
New York
$7.53K -$4.2K -194 -32%
EDRH
15
Edmond de Rothschild Holding
Switzerland
$4.87K – – –
TRCT
16
Tower Research Capital (TRC)
New York
$4K +$4.54K +210 New
Group One Trading
17
Group One Trading
Illinois
$1.18K -$1.99K -92 -59%
Osaic Holdings
18
Osaic Holdings
Arizona
$734 +$865 +40 New
S
19
SignatureFD
Georgia
$292 – – –
Wells Fargo
20
Wells Fargo
California
$106 – – –
LFG
21
Larson Financial Group
Missouri
$48 – – –
Bank of America
22
Bank of America
North Carolina
$24 -$22 -1 -50%
Fidelity Investments
23
Fidelity Investments
Massachusetts
$1 – – –
Millennium Management
24
Millennium Management
New York
– -$20K -1,218 Closed
Citadel Advisors
25
Citadel Advisors
Florida
– -$12K -748 Closed
1
2

TRAW Hedge Fund Activity: Q1 2023 in Review

24 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Traws Pharma (TRAW) for Q1 2023, worth a combined $1.04M — up 3.2% from $1.01M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of TRAW and 3 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 1 added.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $24.6K. The largest seller was Beacon Pointe Advisors, cutting an estimated $22.7K.

  • 24 institutional investors held Traws Pharma (TRAW) as of Q1 2023, down from 28 in Q4 2022.
  • Funds reported $1.04M of Traws Pharma stock for Q1 2023, up 3.2% quarter-over-quarter.
  • 3 funds opened new Traws Pharma positions in Q1 2023 and 6 closed out, a net change of -3 holders.
  • The largest Traws Pharma buyer in Q1 2023 was Susquehanna International Group, an estimated $24.6K added.
  • The largest Traws Pharma seller in Q1 2023 was Beacon Pointe Advisors, an estimated $22.7K sold.

Based on aggregated 13F filings for Q1 2023.